Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelli R McAlpine

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Chemistry & Biology|May 5, 2004
Understanding diseases via receptor regulationShelli R McAlpine
Bioorganic Chemistry|May 15, 2015
Predicting the unpredictable: Recent structure-activity studies on peptide-based macrocyclesHendra Wahyudi, Shelli R McAlpine
Future Medicinal Chemistry|February 17, 2015
Heat-shock protein 90 inhibitors: will they ever succeed as chemotherapeutics?Yao Wang, Shelli R McAlpine
Organic Letters|January 25, 2018
Improving the Cell Permeability of Polar Cyclic Peptides by Replacing Residues with Alkylated Amino Acids, Asparagines, and d-Amino AcidsLaura K Buckton, Shelli R McAlpine
Molecules (Basel, Switzerland)|January 18, 2013
Solid phase versus solution phase synthesis of heterocyclic macrocyclesSeong Jong Kim, Shelli R McAlpine
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targetsJeanette R McConnell, Shelli R McAlpine
Bioorganic & Medicinal Chemistry Letters|December 6, 2012
Halting metastasis through CXCR4 inhibitionDeborah M Ramsey, Shelli R McAlpine
Chemical Communications (Cambridge, England)|December 22, 2018
Protein-protein inhibitor designed de novo to target the MEEVD region on the C-terminus of Hsp90 and block co-chaperone activityMarwa N Rahimi, Shelli R McAlpine
Bioorganic Chemistry|March 10, 2022
Delivering hydrophilic peptide inhibitors of heat shock protein 70 into cancer cellsZifei Han, Shelli R McAlpine, Robert Chapman
Organic & Biomolecular Chemistry|December 11, 2013
Dimerization of a heat shock protein 90 inhibitor enhances inhibitory activityHendra Wahyudi, Yao Wang, Shelli R McAlpine
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Chemistry & Biology|May 5, 2004
Understanding diseases via receptor regulationShelli R McAlpine
Bioorganic Chemistry|May 15, 2015
Predicting the unpredictable: Recent structure-activity studies on peptide-based macrocyclesHendra Wahyudi, Shelli R McAlpine
Future Medicinal Chemistry|February 17, 2015
Heat-shock protein 90 inhibitors: will they ever succeed as chemotherapeutics?Yao Wang, Shelli R McAlpine
Organic Letters|January 25, 2018
Improving the Cell Permeability of Polar Cyclic Peptides by Replacing Residues with Alkylated Amino Acids, Asparagines, and d-Amino AcidsLaura K Buckton, Shelli R McAlpine
Molecules (Basel, Switzerland)|January 18, 2013
Solid phase versus solution phase synthesis of heterocyclic macrocyclesSeong Jong Kim, Shelli R McAlpine
Bioorganic & Medicinal Chemistry Letters|March 5, 2013
Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targetsJeanette R McConnell, Shelli R McAlpine
Bioorganic & Medicinal Chemistry Letters|December 6, 2012
Halting metastasis through CXCR4 inhibitionDeborah M Ramsey, Shelli R McAlpine
Chemical Communications (Cambridge, England)|December 22, 2018
Protein-protein inhibitor designed de novo to target the MEEVD region on the C-terminus of Hsp90 and block co-chaperone activityMarwa N Rahimi, Shelli R McAlpine
Bioorganic Chemistry|March 10, 2022
Delivering hydrophilic peptide inhibitors of heat shock protein 70 into cancer cellsZifei Han, Shelli R McAlpine, Robert Chapman
Organic & Biomolecular Chemistry|December 11, 2013
Dimerization of a heat shock protein 90 inhibitor enhances inhibitory activityHendra Wahyudi, Yao Wang, Shelli R McAlpine
Pageof 7